Illumina Posts 36 Percent Rise in Q1 Revenues; Ups '09 Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that its first-quarter revenues increased 36 percent year over year. Based on the strength of its first-quarter results, the firm upped its revenue guidance for full-year 2009 to a range of $700 million to $720 million.

Illumina generated revenues of $165.8 million for the three-month period ended March 29, compared to revenues of $121.9 million for the first quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.